Report for Foster NL

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (8)

Title : Mixed dementia: emerging concepts and therapeutic implications - Langa_2004_JAMA_292_2901
Author(s) : Langa KM , Foster NL , Larson EB
Ref : Jama , 292 :2901 , 2004
Abstract : Langa_2004_JAMA_292_2901
ESTHER : Langa_2004_JAMA_292_2901
PubMedSearch : Langa_2004_JAMA_292_2901
PubMedID: 15598922

Title : Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease - Doody_2001_Dement.Geriatr.Cogn.Disord_12_295
Author(s) : Doody RS , Dunn JK , Clark CM , Farlow M , Foster NL , Liao T , Gonzales N , Lai E , Massman P
Ref : Dementia & Geriatric Cognitive Disorders , 12 :295 , 2001
Abstract : Doody_2001_Dement.Geriatr.Cogn.Disord_12_295
ESTHER : Doody_2001_Dement.Geriatr.Cogn.Disord_12_295
PubMedSearch : Doody_2001_Dement.Geriatr.Cogn.Disord_12_295
PubMedID: 11351141

Title : Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex - Kuhl_2000_Ann.Neurol_48_391
Author(s) : Kuhl DE , Minoshima S , Frey KA , Foster NL , Kilbourn MR , Koeppe RA
Ref : Annals of Neurology , 48 :391 , 2000
Abstract : Kuhl_2000_Ann.Neurol_48_391
ESTHER : Kuhl_2000_Ann.Neurol_48_391
PubMedSearch : Kuhl_2000_Ann.Neurol_48_391
PubMedID: 10976649

Title : Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer's disease. Pathophysiological implications - Minoshima_1999_Ann.N.Y.Acad.Sci_893_350
Author(s) : Minoshima S , Cross DJ , Foster NL , Henry TR , Kuhl DE
Ref : Annals of the New York Academy of Sciences , 893 :350 , 1999
Abstract : Minoshima_1999_Ann.N.Y.Acad.Sci_893_350
ESTHER : Minoshima_1999_Ann.N.Y.Acad.Sci_893_350
PubMedSearch : Minoshima_1999_Ann.N.Y.Acad.Sci_893_350
PubMedID: 10672264

Title : In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease [see comments] - Kuhl_1999_Neurology_52_691
Author(s) : Kuhl DE , Koeppe RA , Minoshima S , Snyder SE , Ficaro EP , Foster NL , Frey KA , Kilbourn MR
Ref : Neurology , 52 :691 , 1999
Abstract : Kuhl_1999_Neurology_52_691
ESTHER : Kuhl_1999_Neurology_52_691
PubMedSearch : Kuhl_1999_Neurology_52_691
PubMedID: 10078712

Title : Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease - Fontana_1998_Br.J.Clin.Pharmacol_46_221
Author(s) : Fontana RJ , deVries TM , Woolf TF , Knapp MJ , Brown AS , Kaminsky LS , Tang BK , Foster NL , Brown RR , Watkins PB
Ref : British Journal of Clinical Pharmacology , 46 :221 , 1998
Abstract : Fontana_1998_Br.J.Clin.Pharmacol_46_221
ESTHER : Fontana_1998_Br.J.Clin.Pharmacol_46_221
PubMedSearch : Fontana_1998_Br.J.Clin.Pharmacol_46_221
PubMedID: 9764962

Title : An enriched-population, double-blind, placebo-controlled, crossover study of tacrine and lecithin in Alzheimer's disease. The Tacrine 970-6 Study Group - Foster_1996_Dementia_7_260
Author(s) : Foster NL , Petersen RC , Gracon SI , Lewis K
Ref : Dementia , 7 :260 , 1996
Abstract : Foster_1996_Dementia_7_260
ESTHER : Foster_1996_Dementia_7_260
PubMedSearch : Foster_1996_Dementia_7_260
PubMedID: 8872417

Title : The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicity - Fontana_1996_Hepatology_23_1429
Author(s) : Fontana RJ , Turgeon DK , Woolf TF , Knapp MJ , Foster NL , Watkins PB
Ref : Hepatology , 23 :1429 , 1996
Abstract : Fontana_1996_Hepatology_23_1429
ESTHER : Fontana_1996_Hepatology_23_1429
PubMedSearch : Fontana_1996_Hepatology_23_1429
PubMedID: 8675160